Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

3.270 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 971
Open 3.270
Bid (Size) 3.130 (8)
Ask (Size) 3.310 (3)
Prev. Close 3.270
Today's Range 3.270 - 3.270
52wk Range 2.700 - 14.23
Shares Outstanding 305,252,194
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
Via The Motley Fool
Traws Pharma Announces Management Updates
From Traws Pharma, Inc.
Via GlobeNewswire

Performance

YTD
-58.0%
-58.0%
1 Month
-12.3%
-12.3%
3 Month
-54.4%
-54.4%
6 Month
-66.0%
-66.0%
1 Year
-75.3%
-75.3%

More News

Read More
Top 3 Health Care Stocks That Are Set To Fly This Month
Via Benzinga
1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street
Via The Motley Fool
Forecasting The Future: 4 Analyst Projections For Iovance Biotherapeutics
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
What's Wrong With Iovance Biotherapeutics Stock?
Via The Motley Fool
Where Will Iovance Biotherapeutics Be in 5 Years?
Via The Motley Fool
3 Growth Stocks Wall Street Might Be Sleeping On -- But I'm Not
Via The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up?
Via The Motley Fool
These stocks are moving in today's after hours session
Via Chartmill
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
My 3 Favorite Stocks to Buy Right Now
Via The Motley Fool
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Iovance Biotherapeutics Shares Fell Today: What's Going On?
Via Benzinga
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Meet the Growth Stock That Could Soar 280%, According to Wall Street Analysts
Via The Motley Fool
3 Stocks That Could Turn $1,000 Into $5,000 by 2030
Via The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Iovance Biotherapeutics Shares Are Falling Today: What's Going On?
Via Benzinga
3 Mid-Cap Stocks That Could Take Off in 2025
Via The Motley Fool
Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today
Via The Motley Fool

Frequently Asked Questions

Is Iovance Biotherapeutics, Inc. - Common Stock publicly traded?
Yes, Iovance Biotherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Iovance Biotherapeutics, Inc. - Common Stock trade on?
Iovance Biotherapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Iovance Biotherapeutics, Inc. - Common Stock?
The ticker symbol for Iovance Biotherapeutics, Inc. - Common Stock is IOVA on the Nasdaq Stock Market
What is the current price of Iovance Biotherapeutics, Inc. - Common Stock?
The current price of Iovance Biotherapeutics, Inc. - Common Stock is 3.270
When was Iovance Biotherapeutics, Inc. - Common Stock last traded?
The last trade of Iovance Biotherapeutics, Inc. - Common Stock was at 04/09/25 04:00 PM ET
What is the market capitalization of Iovance Biotherapeutics, Inc. - Common Stock?
The market capitalization of Iovance Biotherapeutics, Inc. - Common Stock is 998.17M
How many shares of Iovance Biotherapeutics, Inc. - Common Stock are outstanding?
Iovance Biotherapeutics, Inc. - Common Stock has 998M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.